Key result
Single hs-cTn threshold below 5 ng/L safely rules out MI with near-perfect NPV.
Why the study?
High-sensitivity cardiac troponin discerns MI with high sensitivity, but its application and optimal hs-cTnI and hs-cTnT thresholds for low-risk patient identification in Chinese emergency departments are understudied.
Does a single high-sensitivity cardiac troponin I and T threshold of <5 ng/L safely and rapidly rule out myocardial infarction in Chinese emergency department patients with suspected ACS?
Cohort (n=1,225)
Yes
Does a single high-sensitivity cardiac troponin I and T threshold of <5 ng/L safely and rapidly rule out myocardial infarction in Chinese emergency department patients with suspected ACS?
A single hs-cTnI or hs-cTnT threshold of <5 ng/L at presentation provides excellent sensitivity and negative predictive value for rapidly ruling out MI in Chinese ED patients with suspected ACS.
Answers are grounded in this paper and cite their sources.
May support hs-cTn <5 ng/L for MI rule-out in Chinese ED patients; hypothesis-generating and requires prospective validation before practice change.
BACKGROUND: High-sensitivity cardiac troponin (hs-cTn) discerns MI with high sensitivity, facilitating swift ED discharge. Yet, its application in Chinese cohorts is understudied. This study seeks optimal hs-cTnI and hs-cTnT thresholds for low-risk patient identification in Chinese EDs, utilizing Abbott and Roche assays. METHODS: This prospective, observational cohort study included ED patients suspected of having acute coronary syndrome (ACS). Patients with ST-segment elevation myocardial infarction (STEMI) were excluded. Plasma hs-cTnI and hs-cTnT levels were assessed at presentation. This study evaluated the negative predictive value (NPV) of hs-cTn for 30-day adverse events and targeted ≥99% sensitivity and NPV for MI. The outcomes were compared with those of the clinical hs-cTn assay. RESULTS: Among the 1225 enrolled patients, 365 (29.8%) were confirmed to have MI. A derivation hs-cTnI concentration of <5 ng/L provided a sensitivity of 99.2% and negative predictive value of 99.4% for ruling out MI. For hs-cTnT, sensitivity and NPV were both 100% when the concentration was below 5 ng/L for ruling out MI. The proportions of patients classified as low risk were 42.53% for hs-cTnI and 12.98% for hs-cTnT. Both the hs-cTnI and hs-cTnT thresholds demonstrated high sensitivity and NPV in the prediction of 30-day adverse events. Sex-specific rule-out thresholds (hs-cTnI <6 ng/L, hs-cTnT <8 ng/L) exceeded the unified 5 ng/L, whereas no female-specific threshold was superior for either assay. CONCLUSION: Singular assessment of hs-cTnI and hs-cTnT levels is a rapid and reliable strategy for identifying MI, which may facilitate timely patient discharge from the ED.
No takes yet. Share an insight, caveat, or question.
Fangfang et al. (2026) conducted a cohort in suspected acute coronary syndrome (ACS) (n=1,225). High-sensitivity cardiac troponin I and T thresholds (<5 ng/L) vs. clinical hs-cTn assay was evaluated on Negative predictive value and sensitivity for ruling out MI. A single high-sensitivity cardiac troponin I or T threshold of <5 ng/L provided ≥99.2% sensitivity and ≥99.4% negative predictive value for ruling out myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: